Loading...
NYSE: RMD
ResMed Inc.
Healthcare · Medical - Instruments & Supplies
●S&P 500 since 2017
Market Cap
$33.26B
52w High
$293.81
52w Low
$199.92
P/E
22.46
Volume
897.16K
Outstanding Shares
145.97M
Company profile
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
CEOMichael J. Farrell
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees9,980
IPO dateJun 2, 1995
Valuation
Forward P/E—
EV/EBITDA19.60
Enterprise value$37.5B
Stock splits
Aug 31, 20102:1
Oct 3, 20052:1
Apr 3, 20002:1
Nov 17, 19982:1
Profitability & growth
Revenue growth10.98%
Gross margin60.98%▲4.74%vs FY2024
Operating margin33.81%▲16.25%vs FY2024
ROE23.47%▲11.82%vs FY2024
Analyst consensus
RatingBuy
Target price$295.88▲29.84%
16
Buy
14
Hold
5
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 22, 2026
View
EPS
Actual vs estimate by quarter
Q4FY25
ActualEst.
$2.55
$2.55
Q1FY26
ActualEst.
$2.55
$2.51
Q2FY26
ActualEst.
$2.81
$2.74
Q3FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q4FY25
ActualEst.
$1.35B
$1.35B
Q1FY26
ActualEst.
$1.34B
$1.33B
Q2FY26
ActualEst.
$1.42B
$1.4B
Q3FY26
Next Est.
—